WO2002047718A3 - Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) - Google Patents

Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) Download PDF

Info

Publication number
WO2002047718A3
WO2002047718A3 PCT/US2001/048773 US0148773W WO0247718A3 WO 2002047718 A3 WO2002047718 A3 WO 2002047718A3 US 0148773 W US0148773 W US 0148773W WO 0247718 A3 WO0247718 A3 WO 0247718A3
Authority
WO
WIPO (PCT)
Prior art keywords
methods
vaccination
antigens
chlamydia
compositions
Prior art date
Application number
PCT/US2001/048773
Other languages
French (fr)
Other versions
WO2002047718A2 (en
Inventor
Stephen A Johnston
Katherine Stemke-Hale
Kathryn F Stykes
Bernhard Kaltenboeck
Original Assignee
Univ Texas
Stephen A Johnston
Katherine Stemke-Hale
Kathryn F Stykes
Bernhard Kaltenboeck
Univ Auburn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas, Stephen A Johnston, Katherine Stemke-Hale, Kathryn F Stykes, Bernhard Kaltenboeck, Univ Auburn filed Critical Univ Texas
Priority to AU2002241642A priority Critical patent/AU2002241642A1/en
Publication of WO2002047718A2 publication Critical patent/WO2002047718A2/en
Publication of WO2002047718A3 publication Critical patent/WO2002047718A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination

Abstract

The instant invention relates to antigens and nucleic acids encoding such antigens obtainable by screening a Chlamydia genome. In more specific aspects, the invention relates to methods of isolating such antigens and nucleic acids and to methods of using such isolated antigens for producing immune responses. The ability of an antigen to produce an immune response may be employed in vaccination or antibody preparation techniques.
PCT/US2001/048773 2000-12-15 2001-12-17 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia) WO2002047718A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002241642A AU2002241642A1 (en) 2000-12-15 2001-12-17 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25583900P 2000-12-15 2000-12-15
US60/255,839 2000-12-15

Publications (2)

Publication Number Publication Date
WO2002047718A2 WO2002047718A2 (en) 2002-06-20
WO2002047718A3 true WO2002047718A3 (en) 2003-08-14

Family

ID=22970078

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/048773 WO2002047718A2 (en) 2000-12-15 2001-12-17 Methods and compositions for vaccination comprising nucleic acid ad/or polypeptide sequences of $i(chlamydia)

Country Status (2)

Country Link
AU (1) AU2002241642A1 (en)
WO (1) WO2002047718A2 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212062A (en) * 1991-09-06 1993-05-18 Kansas State University Method and composition to direct Chlamydia psittaci or Chlamydia trachomatis infection
WO1999053948A1 (en) * 1998-04-20 1999-10-28 THE STATE OF OREGON, acting by and through THE STATE BOARD OF HIGHER EDUCATION, on behalf of OREGON STATE UNIVERSITY Chlamydia proteins and their uses
US5989553A (en) * 1995-04-07 1999-11-23 Board Of Regents, The University Of Texas System Expression library immunization
WO2002053588A2 (en) * 2000-12-15 2002-07-11 Board Of Regents, The University Of Texas System Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5212062A (en) * 1991-09-06 1993-05-18 Kansas State University Method and composition to direct Chlamydia psittaci or Chlamydia trachomatis infection
US5989553A (en) * 1995-04-07 1999-11-23 Board Of Regents, The University Of Texas System Expression library immunization
WO1999053948A1 (en) * 1998-04-20 1999-10-28 THE STATE OF OREGON, acting by and through THE STATE BOARD OF HIGHER EDUCATION, on behalf of OREGON STATE UNIVERSITY Chlamydia proteins and their uses
WO2002053588A2 (en) * 2000-12-15 2002-07-11 Board Of Regents, The University Of Texas System Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
KALTENBOECK B ET AL: "FULLY PROTECTIVE VACCINE CANDIDATE GENES OF CHLAMYDIA PSITTACI IDENTIFIED BY RANDOM EXPRESSION LIBRARY IMMUNIZATION", FASEB JOURNAL, FED. OF AMERICAN SOC. FOR EXPERIMENTAL BIOLOGY, BETHESDA, MD, US, vol. 14, no. 6, 20 April 2000 (2000-04-20), pages A1130, XP001109590, ISSN: 0892-6638 *
KALTENBOECK ET AL: "Use of synthetic antigens improves detection by enzyme-linked immunoabsorbent assay of antibodies against abortigenic Chlamydia psittaci in ruminants", JOURNAL OF CLINICAL MICROBIOLOGY, WASHINGTON, DC, US, vol. 35, no. 9, September 1997 (1997-09-01), pages 2293 - 2298, XP002160438, ISSN: 0095-1137 *

Also Published As

Publication number Publication date
AU2002241642A1 (en) 2002-06-24
WO2002047718A2 (en) 2002-06-20

Similar Documents

Publication Publication Date Title
WO2004026265A3 (en) Compositions and methods for treatment of herpesvirus infections
WO1999040188A3 (en) Tumor-associated antigen derivatives from the mage family, and nucleic acid sequences encoding them, used for the preparation of fusion proteins and of compositions for vaccinations
WO2004103269A3 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of the genus borrelia
WO2003049762A3 (en) Immunisation against chlamydia trachomatis
TW200732346A (en) Chimeric hepatitis C virus antigens for eliciting an immune response
AU2003244855A1 (en) Method to enhance an immune response of nucleic acid vaccination
EP2330129A3 (en) Anti-TNF antibodies, compositions, methods and uses
WO2003059381A3 (en) Immunogenic preparations and vaccines on the basis of mrna
EP1935991A3 (en) Nucleic acid vaccines for prevention of flavivirus infection
NZ540544A (en) Nucleic acids and proteins from streptococcus groups A & B
WO2001083559A3 (en) Production and use of protein variants having modified immunogenecity
WO2001096368A3 (en) Use of coiled-coil structural scaffold to generate structure-specific peptides
WO2001063286A3 (en) Method for antigen-specific stimulation of t-lymphocytes with synthetic peptide libraries
WO2001085932A3 (en) Immunogenic polypeptides encoded by mage minigenes and uses thereof
EP1219711A3 (en) Lawsonia intracellularis vaccine
WO2002053588A3 (en) Methods and compositions for vaccination comprising nucleic acid and/or polypeptide sequences of chlamydia psittaci
WO2000006736A3 (en) Nucleic acids and proteins from group b streptococcus
WO2004098526A3 (en) Anti-cancer dna vaccine employing plasmids encoding signal sequence, mutant oncoprotein antigen, and heat shock protein
WO2001032882A3 (en) Nucleic acids and proteins from group b streptococcus
WO2002020038A3 (en) Method for down-regulating ige
WO2005035779A3 (en) Method
AU5554301A (en) Isolation and characterization of the csa operon (etec-cs4 pili) and methods of using same
WO2000063385A3 (en) Nucleic acid immunization
WO2002063010A3 (en) Method of producing recombinant antibodies against tumors
WO2002028998A3 (en) Chlamydia pmp proteins, gene sequences and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP